New dialysis anemia drug tested for safety in 2,200 patients
NCT ID NCT06520826
First seen Mar 14, 2026 · Last updated May 17, 2026 · Updated 6 times
Summary
This study looks at the safety of a drug called vadadustat for treating anemia in people with kidney failure who are on dialysis. About 2,200 adults will be randomly assigned to take vadadustat three times a week or continue standard care. The goal is to see if this dosing schedule is safe and helps manage anemia long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA OF CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dallas Renal Group
Dallas, Texas, 75230, United States
-
Nephrology and Hypertension Specialists, PC
Dalton, Georgia, 30720, United States
-
US Renal Care - Gallup
Gallup, New Mexico, 87301, United States
-
US Renal Care - Live Oak
Live Oak, Texas, 78233, United States
-
USRC Kidney Research
Lone Tree, Colorado, 80124, United States
Conditions
Explore the condition pages connected to this study.